maj
2022
In an upcoming call SciLife Lab’s DDD platform and OligoNova are looking for project ideas for new therapeutic oligonucleotides that can be developed at DDD and OligoNova. Approved project ideas will be developed in close collaboration between the academic laboratory and drug development experts at DDD and OligoNova. The costs of the projects will mainly be covered OligoNova Hub, but academic partners will be expected to contribute.
The call will open March 28. A Digital Information Meeting will be held April 4, 2022 at 14.00–15.00. At the meeting, there will be a presentation of the call and you as an applicant will have the opportunity to ask questions about the call and the application process. Detailed instructions and information about the call and the digital information meeting will be available from March 28 on the homepages of OligoNova (www.oligonova.org) and SciLifeLab’s DDD platform (https://www.scilifelab.se/units/ddd-platform/).
OligoNova is a Swedish initiative addressing challenges in Research & Development of therapeutic oligonucleotides and supporting the development of novel therapies. The OligoNova Hub is based in Gothenburg and is part of SciLifeLab’s Drug Discovery and Development (DDD) platform.
